Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents

Documenti analoghi

• The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
  di: Cyprian Olchowy, et al.
  Pubblicazione: (2017-01-01)
• Differences in hypersensitivity reactions and gadolinium deposition disease/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases VigiBase, FAERS, and IQVIA-MIDAS
  di: Han Qu, et al.
  Pubblicazione: (2024-08-01)
• Impact of gadolinium-based MRI contrast agent and local anesthetics co-administration on chondrogenic gadolinium uptake and cytotoxicity
  di: Alexander Zimmerer, et al.
  Pubblicazione: (2024-04-01)
• Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
  di: Kim Hyo Jeong, et al.
  Pubblicazione: (2010-01-01)
• Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
  di: Atiya Fatima, et al.
  Pubblicazione: (2021-09-01)